Nifty is expected to surpass the intraday all-time high of 16,702
The BSE MidCap and SmallCap indices settled 1.5 per cent and 1.7 per cent higher, respectively
The stock was quoting lower for the fifth straight day, down 1.6 per cent at Rs 262.60 on the BSE in intra-day trade on Tuesday
Shares of IRB Infrastructure Developers jumped over 5 per cent, GMR Infrastructure added 2 per cent and Larsen & Toubro Ltd (LT) recovered following five days of bear hammering
The stock listed at Rs 525, a 3 per cent discount against its issue price of Rs 541 on the BSE
Battrixx said it has received its single largest order to supply 8000 battery packs for Joy E-Bike (electric two-wheelers) produced by WardWizard
The company would be setting up an Asset Management Company and the Trustee Company to sponsor the MF
The stock got listed at Rs 329.95, a 7 per cent discount to the issue price of Rs 353 on the BSE
The company will hold a board meeting on August 26, 2021, to consider and approve split of equity shares of the company, subject to approval of the shareholders
The Board of Eicher Motors decided to unanimously reappoint Siddhartha Lal as managing director (MD) with a revised remuneration package
SBI LIFE has been consolidating in a narrow range near its lifetime high zone from the past few trading weeks, indicating the formation of a strong base before another round of rally
Financial details of deal not disclosed; HCL will modernise and standardise workplace services for more than 16,000 Munich Re employees
Including Monday's intra-day fall of 9.6 per cent, the stock of Ujjivan Small Finance Bank has tumbled 31 per cent in six days
Sectorally, the Nifty IT index advanced 2 per cent while the Nifty Auto index tumbled 1.5 per cent
On July 29, 2021 the board approved scheme of arrangement, which envisages the transfer of the entire balance of Rs 837.43 crore standing to the credit of the general reserve to the retained earnings
India Ratings & Research has downgraded the company's long term issuer rating to 'IND D', from 'IND A'
With this fundraise, the company completes the capital requirement needed for growth and navigating any uncertainties
The stock rebound from its opening level of Rs 471 and moved higher to Rs 538.60 on the BSE in intra-day trade
Aurobindo Pharma, on August 12, 2021, had entered into binding agreements with Cronus Pharma Specialities India Private Limited for acquisition of 51 per cent ownership
Market regulator Sebi kept the proposed Rs 4,500-crore initial share-sale of edible oil major Adani Wilmar in "abeyance"